Control Bionics set to enter the ASX bourse next week; inspired by Stephen Hawking and already FDA approved

assortment of Control Bionics devices

Medtech company Control Bionics (ASX:CBL) will list on the ASX next week.  The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so through electronic devices that pick up their neuroelectric systems. Examples of such conditions include motor-neuron disease, cerebral palsy, and spinal cord injuries. Control Bionics’ flagship product, NeuroNode 3, is watch-sized […]